Detrusor smooth muscle (DSM) defects are responsible for some forms of bladder dysfunction, such as overactive bladder secondary to detrusor overactivity. In this Review, the author examines the role of K+channels in normal and dysfunctional DSM, the methods used to study their activity, and how these channels might be targeted therapeutically with the use of gene therapy approaches and specific inhibitors or activators.
